Low serum pepsinogen i and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community

International Journal of Cancer

Volumn 130, Issue 7, 2012, Pages 1614-1619

  Zhang, Xianghong ^a   Xue, Liying ^a   Xing, Lingxiao ^a   Wang, Junling ^a   Cui, Jinfeng ^a   Mi, Jianmin ^b   Xing, Xin ^a   Wang, Juan ^a   Du, Zhanjun ^b   Misumi, Junichi ^c   Tian, Qingbao ^a   Wang, Liqin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Zanhuang County Hospital   (China)

^c OITA UNIVERSITY   (Japan)

Author keywords

gastric cancer; Helicobacter pylori; pepsinogen

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RURAL POPULATION; STOMACH CARCINOMA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; RISK FACTORS; RURAL POPULATION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856328505     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26172     Document Type: Article

References (35)

1. Adamu MA, Weck MN, Rothenbacher D, Brenner H,. Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population based cohort study. Int J Cancer 2011; 128: 1652-8.
2. Inoue M, Kobayashi S, Matsuura A, Hamajima N, Tajima K, Tominaga S,. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1998; 7: 261-3. (Pubitemid 28353939)
3. Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, Doi Y, Shikata K, Yonemoto K, Shirota T, Matsumoto T, Iida M,. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 2006; 163: 629-37.
4. Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, Ichinose M,. Serum pepsinogen and gastric cancer screening. Intern Med 2007; 46: 261-6. (Pubitemid 46488392)
5. Correa P,. Serum pepsinogens in gastric cancer screening. Dig Dis Sci 2010; 55: 2123-5.
6. Kwak MS, Kim N, Lee HS, Lee HE, Jung HC, Song IS,. Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histologic risk index. Dig Dis Sci 2010; 55: 2275-82.
7. Korstanje A, den Hartog G, Biemond I, Lamers CB,. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl 2002; 236: 22-6. (Pubitemid 35247372)
8. Miki K,. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006; 9: 245-53. (Pubitemid 44846546)
9. Mizuno S, Kobayashi M, Tomita S, Miki I, Masuda A, Onoyama M, Habu Y, Inokuchi H, Watanabe Y,. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer 2009; 12: 158-63.
10. Sun X, Mu R, Zhou Y, Dai X, Zhang S, Huangfu X, Sun J, Li L, Lu F, Qiao Y,. Analysis of mortality rate of stomach cancer and its trend in twenty years in China. Zhonghua Zhong Liu Za Zhi 2004; 26: 4-9.
11. You WC, Blot WJ, Zhang L, Kneller RW, Li JY, Jin ML, Chang YS, Zeng XR, Zhao L, Fraumeni JF, Jr, Xu GW, Samloff MI,. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer. Cancer Epidemiol Biomarkers Prev 1993; 2: 113-7.
12. Sun LP, Gong YH, Wang L, Yuan Y,. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. World J Gastroenterol 2007; 13: 6562-7.
13. Li Y, Zhang X, Huang B, Wang JL, Mi JM, Shen HT, Zhang ZG, Yan X, Xing LX, Wang SJ,. Studies on the cutoff value of serum pepsinogen abnormality for the screen of chronic atrophic gastritis and gastric carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi 2006; 27: 840-4.
14. Zhang XH, Huang B, Wang JL, Li YH, Mi JM, Shen HT, Zhang ZG, Yan X, Xing LX, Wang SJ,. Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer. Zhonghua Zhong Liu Za Zhi 2006; 28: 507-11.
15. Aoki K, Kihaile PE, Zhao W, Zhang X, Castro M, Disla M, Nyambo TB, Misumi J,. Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann Epidemiol 2005; 15: 598-606.
16. Zhang X, Bu Y, Wang J, Yan X, Mi J, Zhao W, Zhang Z, Yang Y, Misumi J, Aoki K,. Follow up observation of gastric mucosal changes in subjects with abnormal PG levels. Zhongguo Zhong Liu Lin Chuang 2000; 27: 491-4 (in Chinese).
17. Compare D, Rocco A, Nardone G,. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci 2010; 14: 302-8.
18. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ,. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
19. Webb PM, Yu MC, Forman D, Henderson BE, Newell DG, Yuan JM, Gao YT, Ross RK,. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67: 603-7. (Pubitemid 26300973)
20. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M,. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54: 764-8. (Pubitemid 40732089)
21. Mizuno S, Miki I, Ishida T, Yoshida M, Onoyama M, Azuma T, Habu Y, Inokuchi H, Ozasa K, Miki K, Watanabe Y,. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci 2010; 55: 3132-7.
22. Zhang X, Sun X, Zhao W,. Seroepidemiological study on Helicobactor pylori infection in rural adult residents. Zhonghua Liu Xing Bing Xue Za Zhi 1999; 20: 212-4.
23. Kokkola A, Louhimo J, Puolakkainen P, Alfthan H, Haglund C, Rautelin H,. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol 2005; 11: 1032-6. (Pubitemid 40347758)
24. Yamaoka M, Nakajima S,. Prevalence of subjects at a high or very high risk of gastric cancer in Japan. Gut Liver 2009; 3: 95-100.
25. Samloff IM,. Pepsinogens, pepsins, and pepsin inhibitors. Gastroenterology 1971; 60: 586-604.
26. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G,. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93: 1090-6. (Pubitemid 29080956)
27. Varis K, Sipponen P, Laxén F, Samloff IM, Huttunen JK, Taylor PR, Heinonen OP, Albanes D, Sande N, Virtamo J, Härkönen M,. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol 2000; 35: 950-6.
28. Väänänen H, Vauhkonen M, Helske T, Kääriä inen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M, Jussila A, et al. Non-endoscopic diagnosis of atrophic gastritis with blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-91. (Pubitemid 36904458)
29. Ren JS, Kamangar F, Qiao YL, Taylor PR, Liang H, Dawsey SM, Liu B, Fan JH, Abnet CC,. Serum pepsinogens and risk of gastric and oesophageal cancers in the general population nutrition intervention trial cohort. Gut 2009; 58: 636-42.
30. Parsonnet J, Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD,. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1993; 2: 461-6.
31. He Y, Hou J, Liu T, Zhang G,. The association between cancer mortality and socioeconomy status from 1990-1992 in Hebei province, China. China Tumor Bull 1996; 5: 11 (in Chinese).
32. Zhao P, Kong LZ,. Mortality rate of stomach cancer: cancer mortality in China. Beijing: People's Health Press, 2009. 307.
33. Konturek PC, Konturek SJ, Brzozowski T,. Helicobacter pylori infection in gastric carcinogenesis. J Physiol Pharmacol 2009; 60: 3-21.
34. Mbulaiteye SM, Hisada M, El-Omar EM,. Helicobacter pylori associated global gastric cancer burden. Front Biosci 2009; 14: 1490-504.
35. Singh K, Ghoshal UC,. Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 2006; 12: 1346-51.